Corrigendum to "Peptide XIB13 reduces capillary leak in a rodent burn model" [Microvasc. Res. 93 (2014) 98-104] Doi: 10.1016/j.mvr.2014.04.003;Peptide XIB13 reduces capillary leak in a rodent burn model

Microvascular Research

Volumn 93, Issue , 2014, Pages 98-104

  Goertz, Ole ^a   Lauer, Henrik ^a   von der Lohe, Leon ^a   Lehnhardt, Marcus ^a   Schossleitner, Klaudia ^b   Petzelbauer, Max ^b   Petzelbauer, Peter ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PROTEIN XIB13; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CGN PROTEIN, HUMAN; GLYCYL-ARGINYL-ARGINYL-PROLYL-LEUCYL-GLYCYL-GLYCYL-ISOLEUCYL-SERYL-GLYCYL-GLYCINE; OLIGOPEPTIDE; PEPTIDE FRAGMENT;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CAPILLARY LEAK SYNDROME; CELL CULTURE; CELL INTERACTION; CELL JUNCTION; CELL STRESS; CELL SURVIVAL; CONTROLLED STUDY; CYTOSKELETON; EDEMA; EPIFLUORESCENCE MICROSCOPY; IN VITRO STUDY; LEUKOCYTE; MALE; MICROCIRCULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; ANIMAL; BURNS; CAPILLARY; CAPILLARY PERMEABILITY; CELL COMMUNICATION; DISEASE MODEL; DRUG EFFECTS; FLUORESCENCE MICROSCOPY; HAIRLESS MOUSE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; STRESS FIBER; TIME; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND HEALING;

ANIMALS; BURNS; CAPILLARIES; CAPILLARY PERMEABILITY; CELL COMMUNICATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EDEMA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES; MALE; MEMBRANE PROTEINS; MICE, HAIRLESS; MICROCIRCULATION; MICROFILAMENT PROTEINS; MICROSCOPY, FLUORESCENCE; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; STRESS FIBERS; TIME FACTORS; WOUND HEALING;

EID: 84901218420     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2015.03.004     Document Type: Erratum

References (25)

1. Aijaz S., et al. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev. Cell 2005, 8:777-786.
2. Battal M.N., et al. Reduction of progressive burn injury by a stable prostaglandin I2 analogue, beraprost sodium (Procylin): an experimental study in rats. Burns 1996, 22:531-538.
3. Birukova A.A., et al. Mechanotransduction by GEF-H1 as a novel mechanism of ventilator-induced vascular endothelial permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L837-L848.
4. Boykin J.V., et al. In vivo microcirculation of a scald burn and the progression of postburn dermal ischemia. Plast. Reconstr. Surg. 1980, 66:191-198.
5. Choi M., et al. Preventing the infiltration of leukocytes by monoclonal antibody blocks the development of progressive ischemia in rat burns. Plast. Reconstr. Surg. 1995, 96:1177-1185. (discussion 1186-7).
6. D'Atri F., et al. Evidence for a functional interaction between cingulin and ZO-1 in cultured cells. J. Biol. Chem. 2002, 277:27757-27764.
7. Goertz O., et al. Burn model for in vivo investigations of microcirculatory changes. Eplasty 2009, 9:e13.
8. Goertz O., et al. Orthogonal polarization spectral imaging: a tool for assessing burn depths?. Ann. Plast. Surg. 2010, 64:217-221.
9. Goertz O., et al. Intravital pathophysiologic comparison of frostbite and burn injury in a murine model. J. Surg. Res. 2011, 167:e395-e401.
10. Goertz O., et al. Influence of anti-inflammatory and vasoactive drugs on microcirculation and angiogenesis after burn in mice. Burns 2011, 37:656-664.
11. Goertz O., et al. Extracorporeal shock waves improve angiogenesis after full thickness burn. Burns 2012, 38:1010-1018.
12. Groger M., et al. A previously unknown dermal blood vessel phenotype in skin inflammation. J. Invest. Dermatol. 2007, 127:2893-2900.
13. Grunwald T.B., Garner W.L. Acute burns. Plast. Reconstr. Surg. 2008, 121:311e-319e.
14. Guillemot L., et al. Cingulin is dispensable for epithelial barrier function and tight junction structure, and plays a role in the control of claudin-2 expression and response to duodenal mucosa injury. J. Cell Sci. 2012, 125:5005-5014.
15. Gunji H., et al. Clinical effectiveness of an ointment containing prostaglandin E1 for the treatment of burn wounds. Burns 1996, 22:399-405.
16. Hashimoto I., et al. The features of thrombus in a microvessel injury model and the antithrombotic efficacy of heparin, urokinase, and prostaglandin E1. Plast. Reconstr. Surg. 2003, 111:2307-2314.
17. Knezevic I.I., et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J. Biol. Chem. 2009, 284:5381-5394.
18. Langer S., et al. New model for in vivo investigation after microvascular breakdown in burns: use of intravital fluorescent microscopy. Burns 2005, 31:168-174.
19. Mehta D., Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 2006, 86:279-367.
20. Mileski W.J., et al. Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury. J. Trauma 2003, 54:950-958.
21. Mitsunaga Junior J.K., et al. Rat an experimental model for burns: a systematic review. Acta Cir. Bras. 2012, 27:417-423.
22. Robson M.C., et al. The effect of prostaglandins on the dermal microcirculation after burning, and the inhibition of the effect by specific pharmacological agents. Plast. Reconstr. Surg. 1979, 63:781-787.
23. Singh V., et al. The pathogenesis of burn wound conversion. Ann. Plast. Surg. 2007, 59:109-115.
24. Tian X., et al. Control of vascular permeability by atrial natriuretic peptide via a GEF-H1-dependent mechanism. J. Biol. Chem. 2014, 289:5168-5183.
25. Zhu H., et al. Nitric oxide accelerates the recovery from burn wounds. World J. Surg. 2007, 31:624-631.